G Bussolati

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. ncbi Oxytocin and oxytocin receptors in cancer cells and proliferation
    P Cassoni
    Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy
    J Neuroendocrinol 16:362-4. 2004
  2. ncbi Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification
    G Bussolati
    Department of Biomedical Sciences and Oncology, University of Torino, Italy
    Virchows Arch 437:360-4. 2000
  3. ncbi 111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Torino, Vai Santena 7, 10126 Torino, Italy
    Cancer Res 61:4393-7. 2001
  4. ncbi Classic and recent special stains used in differential diagnosis of endocrine tumors
    G Bussolati
    Department of Biomedical Sciences and Oncology, University of Turin, Via Santena 7, I 10126 Turin, Italy
    Endocr Pathol 12:379-87. 2001
  5. ncbi Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy
    M Papotti
    Department of Biomedical Sciences and Oncology, University of Turin, Torino, Italy
    Virchows Arch 439:787-97. 2001
  6. ncbi 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast
    M Papotti
    Department of Biomedical Sciences and Oncology, University of Turin, Torino, Italy
    Appl Immunohistochem Mol Morphol 9:229-33. 2001
  7. ncbi Proper detection of the nuclear shape: ways and significance
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Torino, Italy
    Rom J Morphol Embryol 49:435-9. 2008
  8. ncbi Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer
    G Cserni
    Bacs Kiskun County Teaching Hospital, Kecskemet, Hungary
    Br J Surg 91:1245-52. 2004
  9. ncbi Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, 10126, Italy
    J Cell Mol Med 9:438-45. 2005
  10. ncbi A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Turin, Torino, Italy
    Br J Cancer 92:1261-7. 2005

Collaborators

Detail Information

Publications30

  1. ncbi Oxytocin and oxytocin receptors in cancer cells and proliferation
    P Cassoni
    Department of Biomedical Sciences and Human Oncology, University of Torino, Torino, Italy
    J Neuroendocrinol 16:362-4. 2004
    ....
  2. ncbi Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification
    G Bussolati
    Department of Biomedical Sciences and Oncology, University of Torino, Italy
    Virchows Arch 437:360-4. 2000
    ....
  3. ncbi 111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Torino, Vai Santena 7, 10126 Torino, Italy
    Cancer Res 61:4393-7. 2001
    ..The present study opens new perspectives for imaging and, possibly, therapy of OTR-positive human tumors such as breast and endometrial carcinomas, neuroblastomas, and glioblastomas...
  4. ncbi Classic and recent special stains used in differential diagnosis of endocrine tumors
    G Bussolati
    Department of Biomedical Sciences and Oncology, University of Turin, Via Santena 7, I 10126 Turin, Italy
    Endocr Pathol 12:379-87. 2001
    ....
  5. ncbi Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy
    M Papotti
    Department of Biomedical Sciences and Oncology, University of Turin, Torino, Italy
    Virchows Arch 439:787-97. 2001
    ..IHC can therefore be usefully coupled to radionuclear investigations to better characterize the sst cellular location and subtype in lung tumors...
  6. ncbi 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast
    M Papotti
    Department of Biomedical Sciences and Oncology, University of Turin, Torino, Italy
    Appl Immunohistochem Mol Morphol 9:229-33. 2001
    ..HMW CK can be added to the list of markers useful in the differential diagnosis of NE from non-NE tumors...
  7. ncbi Proper detection of the nuclear shape: ways and significance
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Torino, Italy
    Rom J Morphol Embryol 49:435-9. 2008
    ..Finally, the prognostic importance of detecting irregularities of the nuclear shape in breast carcinomas by immunofluorescence staining for nuclear proteins will be discussed...
  8. ncbi Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer
    G Cserni
    Bacs Kiskun County Teaching Hospital, Kecskemet, Hungary
    Br J Surg 91:1245-52. 2004
    ..The need for further axillary treatment in patients with breast cancer with low-volume sentinel node (SN) involvement (micrometastases or smaller) is controversial...
  9. ncbi Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, 10126, Italy
    J Cell Mol Med 9:438-45. 2005
    ..This original methodology of incorporating Tissue Arrays into paraffin blocks as fiducial markers for three-dimensional reconstruction has a potential impact on histology for research purposes and diagnostic applications...
  10. ncbi A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
    G Bussolati
    Department of Biomedical Sciences and Human Oncology, University of Turin, Torino, Italy
    Br J Cancer 92:1261-7. 2005
    ..Biotinylated Trastuzumab can thus be used for immunohistochemical detection of HER-2 overexpression in breast cancer, and has the potential to identify patients likely to benefit from Trastuzumab treatment...
  11. ncbi Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study
    A Sapino
    Dipartimento di Scienze Biomediche e Oncologia Umana, Universita di Torino, Torino, Italy
    Ann Oncol 18:1963-8. 2007
    ..We previously showed that BiotHER immunoreactivity is highly correlated with HER2 amplification and indicated that it could be associated with better clinical outcome in advanced breast cancer patients receiving trastuzumab...
  12. ncbi [Histological sectioning of brush bristles allows an improved diagnosis of biliary tract lesions]
    S Asioli
    Dipartimento di Scienze Biomediche e Oncologia, Universita degli Studi di Torino, Torino, Italy
    Minerva Med 98:373-8. 2007
    ..Small fragments of the mucosa, of inflammatory cell aggregates or of carcinomas are observed and the results are optimally fixed and allow a definitive histological diagnosis...
  13. ncbi A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling
    C Marchio
    Department of Biomedical Sciences and Human Oncology, University of Turin, Torino, Italy
    Histopathology 48:556-62. 2006
    ..To reveal architectural structure and growth patterns of tubular carcinomas (TC) and tubulo-lobular carcinomas (TLC) of the breast...
  14. ncbi Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains
    A Sapino
    Department of Biomedical Sciences and Human Oncology, University of Torino Medical School, Italy
    Histopathology 43:354-62. 2003
    ..Evaluation of HER2 gene amplification in breast cancers is a compelling, routine procedure. The aim of this work was to evaluate which breast carcinomas would really benefit from HER-2/neu gene analysis...
  15. ncbi Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue
    B Chini
    CNR Institute of Neuroscience, Cellular and Molecular Pharmacology Section, Via Vanvitelli 32, 20129 Milano, Italy
    Br J Cancer 89:930-6. 2003
    ..These features makes radiolabelled DOTA-dLVT a very good candidate for the radiotargeting of OTR-expressing tumours...
  16. ncbi Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines
    G Cserni
    Department of Pathology, , , Hungary
    Eur J Cancer 39:1654-67. 2003
    ..e. approximately 2% of all patients initially staged by SN biopsy. The methods for the intraoperative and molecular assessment of SNs are also surveyed...
  17. ncbi Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management
    A Sapino
    Department of Biomedical Sciences and Human Oncology, University of Turin, Italy
    Br J Cancer 88:702-6. 2003
    ..This presurgical protocol is reliable for screening patients with LN metastases that should proceed directly to axillary dissection or adjuvant chemotherapy, thus avoiding sentinel lymph node biopsy...
  18. ncbi Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
    M Papotti
    Department of Biomedical Sciences and Oncology, University of Turin, Via Santena 7, 10126 Turin, Italy
    Virchows Arch 440:461-75. 2002
    ..It is concluded that SSTRs 1-5 are heterogeneously expressed in GEP endocrine tumors and that IHC is a reliable tool to detect SSTR types 2, 3 and 5 in surgical and biopsy specimens...
  19. ncbi A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells
    J F Novak
    Department of Biology, Bucknell University, Lewisburg, Pennsylvania 17837, USA
    Cancer Res 60:3470-6. 2000
    ..Suggested plasminogen activator-OC-OTR/OT interactions may have an effect on the regulation of cell proliferation within the bone tissue as well as properties of the extracellular matrix surrounding the tumor foci in the bone...
  20. ncbi Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
    C Marchio
    The Breakthrough Breast Cancer Research Centre Institute of Cancer Research, London, UK
    J Pathol 215:398-410. 2008
    ..Our results demonstrate that MPCs have distinct histological features and molecular genetic profiles supporting the contention that they constitute a distinct pathological entity...
  21. ncbi [On-site evaluation and triage for endoscopic ultrasound-guided fine needle aspiration cytology. The Turin experience]
    P Campisi
    Dipartimento di Scienze Biomediche e Oncologia, Universita degli Studi di Torino, Torino, Italy
    Minerva Med 98:395-400. 2007
    ....
  22. ncbi Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    L Cataliotti
    University of Florence, Florence, Italy
    Eur J Cancer 43:660-75. 2007
    ..The aim of this paper is to contribute to the increase in the level of care in a breast unit, as the input of qualified health professionals increases the quality of breast cancer patient care...
  23. ncbi Histology far away from Flatland: 3D roller-coasting into grade-dependent angiogenetic patterns in oligodendrogliomas
    P Cassoni
    Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy
    J Cell Mol Med 12:564-8. 2008
    ..We use here surgical specimens derived from oligodendrogliomas as a model for a novel elucidative 3D reconstruction of the grade-dependent vascular arborisation in brain tumours...
  24. ncbi Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms
    A Bartolazzi
    Histopathology 48:212-3. 2006
  25. ncbi Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid
    M Volante
    Departments of Biomedical Sciences and Oncology, University of Turin, Torino, Italy
    J Histochem Cytochem 49:1003-11. 2001
    ..These findings are consistent with an extensive DNA fragmentation peculiar to oxyphilic cells, which is not directly related to apoptosis and whose origin and biological significance are presently unknown...
  26. ncbi Prostatic duct carcinoma with combined prostatic duct adenocarcinoma and urothelial carcinoma features: report of a case
    D Pacchioni
    Department of Urologic Pathology, University of Turin, Italy
    Int J Surg Pathol 12:293-7. 2004
    ..The proliferation index was high (60%), and p53 was diffusely expressed (55%). The incidence and significance of PDC with combined features is discussed with reference to literature data...
  27. ncbi Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study
    C A Wells
    Department of Histopathology, St Bartholomew s Hospital Medical School, West Smithfield, London, EC1A 7BE, United Kingdom
    Virchows Arch 445:119-28. 2004
    ..The Quick score method of receptor assessment may also have too many categories for good concordance, and grouping of these into fewer categories may remove some of the variation among laboratories...
  28. ncbi Growth inhibition of DMBA-induced rat mammary carcinomas by UK 114
    S Racca
    Department of Biological and Clinical Sciences, University of Turin, Italy
    Virchows Arch 431:323-8. 1997
    ..The mechanism of the tumour inhibitory activity of UK 114 is probably related to induction of immunosurveillance...
  29. ncbi Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance?
    A Sapino
    Department of Biomedical Sciences and Human Oncology University of Torino, Torino, Italy
    Histopathology 40:211-4. 2002
  30. ncbi Prognostic significance of the expression of immunohistochemically detectable differentiation markers in laryngeal carcinomas
    G Cortesina
    Clinica Otorinolaringoiatrica, , Italy
    Tumori 75:478-82. 1989
    ..This study indicates that the combined use of morphologic and biologic (immunohistochemical) criteria may constitute an independent parameter of primary importance in predicting the evolution of laryngeal carcinomas...